MedicineNet.com

About Us | Privacy Policy | Site Map
February 9, 2012

olsalazine, Dipentum

GENERIC NAME: olsalazine

BRAND NAME: Dipentum

DRUG CLASS AND MECHANISM: Olsalazine is a derivative of salicylic acid. Inactive by itself, it is converted by the bacteria in the colon to mesalamine. Mesalamine works as an anti-inflammatory agent in treating inflammatory diseases of the intestines. Its benefit is believed to be due to a local effect from within the bowel and, therefore, following oral administration very little (less than 10%) is absorbed. Mesalamine is thought to be the active component of sulfasalazine (Azulfidine). Olsalazine was approved by the FDA in July, 1990.

PRESCRIPTION: yes

GENERIC AVAILABLE: no

PREPARATIONS: Capsules (beige-orange) containing 250mg.

STORAGE: The capsules should be kept at room temperature, 15-30°C (59-86°F).

PRESCRIBED FOR: Olsalazine is used for the treatment of mild to moderately severe ulcerative colitis.

DOSING: Olsalazine is usually administered at a dose of 500mg (two capsules) twice daily. It is taken with meals.

DRUG INTERACTIONS: There are no known drug interactions with olsalazine.

PREGNANCY: It is not known whether olsalazine crosses the placenta to the fetus.

NURSING MOTHERS: It is not known whether olsalazine is secreted into breast milk.

SIDE EFFECTS: Gastrointestinal disturbances commonly occur in persons who take olsalazine. Diarrhea occurs in about 1 of every 6 persons who take it; about one in 20 need to discontinue therapy because the diarrhea is severe. Abdominal pain or cramps occur in 1 in 10 persons, and nausea or vomiting occurs in 1 in 20. Other side effects, including dizziness, depression, and headache, occur less frequently than gastrointestinal effects during therapy. Rashes occurs in 2.3% of persons and joint pain in 4%.

Reference: FDA Prescribing Information


Last Editorial Review: 12/31/1997




Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Pill Identifier Icon

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

MedicineNet Doctors

Suggested Reading on olsalazine, Dipentum by Our Doctors

Women's Health

Find out what women really need.



Symptom Checker: Your Guide to Symptoms & Signs: Pinpoint Your Pain



Related Drugs - WebMD Health Network

olsalazine, Dipentum

What is Crohn's disease?

Crohn's disease (also spelled Crohn disease) is a chronic inflammatory disease of the intestines. It primarily causes ulcerations (breaks in the lining) of the small and large intestines, but can affect the digestive system anywhere from the mouth to the anus. It is named after the physician who described the disease in 1932. It also is called granulomatous enteritis or colitis, regional enteritis, ileitis, or terminal ileitis.

Crohn's disease is related closely to another chronic inflammatory condition that involves only the colon called ulcerative colitis. Together, Crohn's disease and ulcerative colitis are frequently referred to as inflammatory bowel disease (IBD). Ulcerative colitis and Crohn's disease have no medical cure. Once the diseases begin, they tend to fluctuate between periods of inactivity (remission) and activity (relapse).

Inflammatory bowel disease affects approximately 500,000 to two million peop...

Read the Crohn's Disease article »







Use Pill Finder Find it Now

Pill Identifier on RxList

  • quick,
    easy,
    pill identification

Find a Local Pharmacy

  • including
    24 hour
    pharmacies